Icon

DUONEB (nda020950)- (EQ 0.083% BASE;0.017%)

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE MYLAN SPECIALITY LP
EQ 0.083% BASE;0.017%
Yes Yes
2021-Dec-28 Expired
None None
None No
DuoNeb is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.
4 0 4
Total Other Developers None
Drugs with Suitability Yes
EQ 0.083% BASE;0.017% ** ** - 4 -
NDA Sales Available Total Generic Sales Available
No 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ******* ** ***. *********** **** **** ****** *********, **** ********, ***** ******** (**) *****, ****** ****** (***) ***
****** ***** ***** ******* *********** **** ** ****, *-*** ** *-***, *-*** ** *-***, **** ** *-***/*/*/*, *-****, *-***, *-***, *-***, ***** ********** ****, ********, *** ******, ***** (***) ***
****** ***** ***** ******* *********** **** **. * &** ****** ******* ******** ****, ***** **, ********* ****, ****** ******* ******, ***** (***) ***
****** ******** **** *** ******** *********** *********** * ********** ******, ********, ***** ******** (**) *****, ****** ****** (***) ***
****** *** ***** *** ************** ******** ******* *********** ****** **. ** *** ** - ******* :- ***** **** - *****, ***** **********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.